• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发缓解型多发性硬化症患者中存在缺陷的 CD19+CD24-CD38 过渡性 B 细胞功能。

Defective CD19+CD24CD38 transitional B-cell function in patients with relapsing-remitting MS.

机构信息

Department of Brain Sciences, Imperial College London, London, UK.

Department of Brain Sciences, Imperial College London, London, UK/Imperial College Healthcare NHS Trust, London, UK.

出版信息

Mult Scler. 2021 Jul;27(8):1187-1197. doi: 10.1177/1352458520951536. Epub 2020 Sep 14.

DOI:10.1177/1352458520951536
PMID:32924828
Abstract

BACKGROUND

Multiple sclerosis (MS) is characterized by central nervous system (CNS) infiltration of T and B cells, excess inflammatory cytokine and chemokine production and failure of immune regulation. CD19+CD24CD38 transitional B cells producing interleukin (IL)-10 have been shown to suppress interferon-γ (IFNγ) and tumour necrosis factor-α (TNFα) production by CD4+ T cells and to be dysfunctional in autoimmune arthritis and systemic lupus erythematosus.

OBJECTIVE

We hypothesized that transitional B-cell-dependent immune regulation could be defective in MS and examined their function in healthy subjects and patients with relapsing-remitting multiple sclerosis (RRMS).

METHODS

A total of 62 healthy donors and 21 RRMS subjects donated peripheral blood for the study. IL-10-producing B cells, IFNγ and TNFα-producing T cells and proliferating T cells were quantified by flow cytometry.

RESULTS

In healthy individuals, CD19+CD24CD38 transitional B cells produce more IL-10 than CD19+CD24+CD38+ naive and CD19+CD24CD38- memory B cells and are able to suppress CD4+ T-cell proliferation and IFNγ and TNFα-production. In subjects with RRMS, CD19+CD24CD38 transitional B cells produce significantly less IL-10 and to fail to suppress effector T-cell function.

CONCLUSION

CD19+CD24CD38 transitional B cells physiologically represent the most potent regulatory B-cell subset and are functionally defective in patients with RRMS, an abnormality that may contribute to the immune pathological process.

摘要

背景

多发性硬化症(MS)的特征是中枢神经系统(CNS)浸润 T 和 B 细胞、过度产生炎症细胞因子和趋化因子以及免疫调节失败。已经表明,产生白细胞介素(IL)-10 的 CD19+CD24CD38 过渡性 B 细胞可抑制 CD4+T 细胞产生干扰素-γ(IFNγ)和肿瘤坏死因子-α(TNFα),并且在自身免疫性关节炎和系统性红斑狼疮中功能失调。

目的

我们假设过渡性 B 细胞依赖性免疫调节可能在 MS 中存在缺陷,并检查其在健康受试者和复发缓解型多发性硬化症(RRMS)患者中的功能。

方法

共有 62 名健康供体和 21 名 RRMS 受试者捐献外周血进行研究。通过流式细胞术定量测定产生 IL-10 的 B 细胞、产生 IFNγ 和 TNFα 的 T 细胞和增殖的 T 细胞。

结果

在健康个体中,CD19+CD24CD38 过渡性 B 细胞比 CD19+CD24+CD38+幼稚 B 细胞和 CD19+CD24CD38-记忆 B 细胞产生更多的 IL-10,并且能够抑制 CD4+T 细胞增殖和 IFNγ 和 TNFα 的产生。在 RRMS 受试者中,CD19+CD24CD38 过渡性 B 细胞产生的 IL-10 明显减少,并且无法抑制效应 T 细胞的功能。

结论

CD19+CD24CD38 过渡性 B 细胞在生理上代表最有效的调节性 B 细胞亚群,并且在 RRMS 患者中功能失调,这种异常可能导致免疫病理过程。

相似文献

1
Defective CD19+CD24CD38 transitional B-cell function in patients with relapsing-remitting MS.复发缓解型多发性硬化症患者中存在缺陷的 CD19+CD24-CD38 过渡性 B 细胞功能。
Mult Scler. 2021 Jul;27(8):1187-1197. doi: 10.1177/1352458520951536. Epub 2020 Sep 14.
2
CD19CD24CD38 B Cell Dysfunction in Primary Biliary Cholangitis.原发性胆汁性胆管炎中 CD19CD24CD38+B 细胞功能障碍。
Mediators Inflamm. 2020 Feb 10;2020:3019378. doi: 10.1155/2020/3019378. eCollection 2020.
3
CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.CD19+CD24hiCD38hi B 细胞在维持调节性 T 细胞的同时限制 TH1 和 TH17 细胞的分化。
Sci Transl Med. 2013 Feb 20;5(173):173ra23. doi: 10.1126/scitranslmed.3005407.
4
Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.原发性干燥综合征外周调节性细胞免疫表型分析:一项横断面研究
Arthritis Res Ther. 2013;15(3):R68. doi: 10.1186/ar4245.
5
Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19 B cells in patients with ankylosing spondylitis.白细胞介素-35 促进强直性脊柱炎患者 CD19+B 细胞中调节性 B 细胞的扩增和白细胞介素-10 的产生。
Clin Rheumatol. 2022 Aug;41(8):2403-2416. doi: 10.1007/s10067-022-06137-8. Epub 2022 Apr 14.
6
PD-L1 Regulatory B Cells Are Significantly Decreased in Rheumatoid Arthritis Patients and Increase After Successful Treatment.PD-L1 调节性 B 细胞在类风湿关节炎患者中显著减少,并在成功治疗后增加。
Front Immunol. 2018 Oct 1;9:2241. doi: 10.3389/fimmu.2018.02241. eCollection 2018.
7
Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.在复发型多发性硬化症患者中,阿仑单抗治疗后调节性 B 细胞缺陷的恢复。
J Neuroinflammation. 2018 Oct 30;15(1):300. doi: 10.1186/s12974-018-1334-y.
8
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.CD19(+)CD24(hi)CD38(hi) B 细胞在健康个体中表现出调节能力,但在系统性红斑狼疮患者中功能受损。
Immunity. 2010 Jan 29;32(1):129-40. doi: 10.1016/j.immuni.2009.11.009. Epub 2010 Jan 14.
9
Characterization of CD19 CD24 CD38 B cells in Chinese adult patients with atopic dermatitis.中国成年特应性皮炎患者中CD19 CD24 CD38 B细胞的特征分析
J Eur Acad Dermatol Venereol. 2020 Dec;34(12):2863-2870. doi: 10.1111/jdv.16399. Epub 2020 Jul 3.
10
Elevated circulating CD19CD24CD38 B cells display pro-inflammatory phenotype in idiopathic membranous nephropathy.循环中 CD19CD24CD38+B 细胞升高显示特发性膜性肾病的促炎表型。
Immunol Lett. 2023 Sep;261:58-65. doi: 10.1016/j.imlet.2023.08.001. Epub 2023 Aug 6.

引用本文的文献

1
CD38 connects the heart and brain.CD38连接心脏和大脑。
Transl Psychiatry. 2025 Sep 11;15(1):342. doi: 10.1038/s41398-025-03597-9.
2
Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases.开发一种体外方法以评估生物制品在预防传染病中的免疫原性。
Immunol Res. 2025 Sep 3;73(1):126. doi: 10.1007/s12026-025-09681-y.
3
Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management.系统性红斑狼疮中的免疫细胞异常:靶向治疗走向精准管理
Cell Mol Biol Lett. 2025 Jun 16;30(1):73. doi: 10.1186/s11658-025-00749-z.
4
Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies.自身免疫性疾病中调节性B细胞的异质性:对免疫平衡和治疗策略的影响
Immunother Adv. 2025 May 8;5(1):ltaf020. doi: 10.1093/immadv/ltaf020. eCollection 2025.
5
Aberrations in peripheral B lymphocytes and B lymphocyte subsets levels in Parkinson disease: a systematic review.帕金森病外周血B淋巴细胞及B淋巴细胞亚群水平的异常:一项系统评价
Front Immunol. 2025 Mar 31;16:1526095. doi: 10.3389/fimmu.2025.1526095. eCollection 2025.
6
Revealing the role of regulatory b cells in cancer: development, function and treatment significance.揭示调节性B细胞在癌症中的作用:发育、功能及治疗意义
Cancer Immunol Immunother. 2025 Feb 25;74(4):125. doi: 10.1007/s00262-025-03973-w.
7
The correlation between immune cells and endometriosis: a bidirectional two-sample mendelian randomization study.免疫细胞与子宫内膜异位症之间的相关性:一项双向两样本孟德尔随机化研究
BMC Womens Health. 2024 Dec 19;24(1):641. doi: 10.1186/s12905-024-03493-2.
8
Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis.可溶性 CD27 是多发性硬化症中 T 细胞介导的病灶活性的鞘内生物标志物。
J Neuroinflammation. 2024 Apr 12;21(1):91. doi: 10.1186/s12974-024-03077-9.
9
Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine.口服克拉屈滨治疗的多发性硬化症患者免疫细胞亚群和自身反应性的持续影响。
Front Immunol. 2024 Feb 16;15:1327672. doi: 10.3389/fimmu.2024.1327672. eCollection 2024.
10
immune evaluation of adenoviral vector-based platform for infectious diseases.基于腺病毒载体的传染病平台的免疫评估
BioTechnologia (Pozn). 2023 Dec 21;104(4):403-419. doi: 10.5114/bta.2023.132775. eCollection 2023.